Lifestyle

Xanax Recalled Nationwide Over Failed Dissolution Testing

By Mike Harper · April 20, 2026

If you have a bottle of Xanax XR at home, it is worth checking the lot number.

The FDA has issued a nationwide recall of a specific lot of Xanax XR — the extended-release version of the widely prescribed anti-anxiety medication — after the pills failed dissolution testing during quality control review. According to the FDA, the affected product is Xanax XR 3-milligram extended-release tablets, sold in 60-tablet bottles, manufactured in Ireland and distributed by Viatris Specialty LLC of Morgantown, West Virginia.

The recall covers one specific lot: lot number 8177156, with an expiration date of February 28, 2027.

The recall is classified as Class II — meaning the FDA has determined that use of or exposure to the affected product “may cause temporary or medically reversible adverse health consequences” while the probability of serious harm remains remote. No adverse events or patient reactions linked to this specific lot have been reported as of mid-April.

The issue is dissolution. Extended-release formulations like Xanax XR are designed to release the active ingredient slowly over several hours. When dissolution fails specification, it can mean the medication releases too quickly, too slowly, or inconsistently — potentially affecting how well it controls symptoms. The concern is not that the drug is toxic, but that it may not be working as intended.

Viatris initiated the voluntary recall on March 17. The FDA updated the classification on April 15, elevating it to the nationwide Class II designation.

The recalled basil was distributed to pharmacies across the United States between August 2024 and May 2025. Pharmacies are responsible for pulling and returning the stock — the product should no longer be available for purchase. Customers who purchased the affected lot are advised to stop taking it, safely dispose of the pills, and contact their doctor before making any changes to their medication regimen.

Xanax (alprazolam) is one of the most commonly prescribed benzodiazepines in the United States, used primarily to treat panic disorder and generalized anxiety disorder. The recall does not affect any other lot, strength, or formulation of Xanax XR, or any generic alprazolam products. Anyone with questions can contact Viatris customer service or their prescribing physician.